spacer
home > ebr > Spring 2019
PUBLICATIONS

European Biopharmaceutical Review

ebr
Spring 2019

   
Text
PDF
bullet
Biomarkers and Personalised Medicine
Biomarkers for Rare Diseases

Jewel Biomarkers Can Be Found By Digging in the Right Mine

The future of biomarkers is bursting with potential, and surrogate biomarkers are now making way for the development of diagnostic, therapeutic, and prognostic biomarkers, enthuses Professor Hermann Mascher at pharm-analyt Labor.
 
view
download pdf
Biomarkers: The Promise of Personalised Medicine

The Road to Success

Dr Karen Hills and Professor Ken Smith at PredictImmune revisit the history of biomarkers and draw comparisons to more modern examples, demonstrating how biomarkers have become drivers for a more personalised approach to medicine.
 
view
download pdf
Predicting the Health of Future Generations with High-Resolution NMR

Trusting in Biobanking

Professor Matthias Nauck at University Medicine Greifswald introduces nuclear magnetic resonance spectroscopy as a means to enhance biobanking, ultimately progressing modern research techniques such as genomics and personalised medicine.
 
view
download pdf
bullet
Cell Therapy
Laying the Foundation for Successful Advanced Therapies

Bridging the Gap

It is more important than ever for apheresis centres to keep up with the quickly evolving cell therapy landscape, and particular attention needs to be paid to starting materials, urge Dominic Clarke PhD and Brad N Taylor PhD at HemaCare.
 
view
download pdf
Cell and Gene Therapy Development

Opportunities and Challenges in Cancer Innovations

Following some suggestions that almost all cancer treatments will eventually be based on cell and gene therapy approaches, Dr Ger Brophy at Avantor takes a step back to evaluate their progress and what is needed to reap their full potential.
 
view
download pdf
bullet
Discovery and Development Technology
Making Metabolites

Accessing Difficult-to-Synthesise Metabolites in Drug Development Programmes

Julia Shanu-Wilson at Hypha Discovery reviews case studies where different metabolite types, accessed through biological means, have been utilised and summarises the challenges and solutions met in their provision.
 
view
download pdf
Rewriting Drug Discovery and Development

The Authenticity of Synthetics

The impact of synthetic biology is forecast to be broad, as explained by Evonetix’s Dr Tim Brears who sheds light on its potential to empower drug discovery, with particular regard towards DNA sequencing.
 
view
download pdf
bullet
ATMPs and Immunoncology
Q&A: The Growth of Advanced Therapy Medicinal Products

A New Class of Innovation

eXmoor Pharma Concepts’ Dr Angela Obsorne talks to EBR about the promise of advanced therapy medicinal products and the impact of Brexit on the UK's approach to these.
 
view
download pdf
bullet
Features
Ligand-Receptor Identification Methodologies

Details Matter

Protein-protein interaction technologies can only go so far in detecting extracellular interactions, begging the need for alternative methodologies, express Dr Maria P Pavlou and Dr Paul Helbling at Dualsystems Biotech.
 
view
download pdf
Improving Study Outcomes

eCOA Technology in Vaccine Clinical Trials

Vaccine development can be hindered by the processing of large volumes of manual data. Katie Garner at CRF Bracket demonstrates how integrating electronic clinical outcome assessment can combat the burden.
 
view
download pdf
Measuring the Overall Cost of Clinical Drug Trials in Canada

Pricing Clinical Research in the Canadian Industry

Canadian R&D is gaining momentum as the federal and provincial governments gauge the necessary tools to progress innovation. Dr Dat T Tran and Dr Ilke Akpinar at the Institute of Health Economics and Dr Philip Jacobs at the University of Alberta explore further.
 
view
download pdf
Maturing Approaches for the Production of Viral Vectors

Anticipating Advancements

Antony Hitchcock at Cobra Biologics talks supply and demand following the FDA’s prediction that 40 gene therapy products will be licensed by 2020.
 
view
download pdf
The Manufacturing- Regulatory Continuum

Connecting ERP and RIM Data

Erick Gaussens PhD at ProductLife Group divulges the findings from a recent roundtable debate among industry experts focussed on improved data exchange.
 
view
download pdf
   
spacer
Edited by
Dr Deborah O'Neil,
Chief Executive and Scientific Officer,
NovaBiotics Ltd
Published quarterly in
January, April,
July, and October

News and Press Releases

Peli BioThermal Key Speakers at CTS Europe

Peli BioThermal, the global name in temperature controlled packaging, will highlight the rise of reusable temperature controlled packaging as guest speakers at Clinical Trial Supply Europe, being held in Milan on March 13 – 14, 2019.
More info >>

White Papers

Backward Thinking

Development of a generic equivalent to a current marketed pressurized metered dose inhaler (pMDI) product brings immense challenges. Thorough analysis is critical to gain a comprehensive understanding of the physical attributes and pharmaceutical performance of the reference marketed product. Many factors need to be assessed, understood and combined in order to successfully develop a generic pMDI which will meet the regulatory and quality requirements as an equivalent product in the anticipated target market.
More info >>

Industry Events

LogiPharma 2019

9-11 April 2019, Montreux Music & Convention Centre

LogiPharma is the world’s leading pharma supply chain event. With over 950+ pharma supply chain leaders exclusively meeting in one place at one time, LogiPharma is THE meeting place to benchmark your business with the best pharma companies and shape the future of your industry.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement